Your browser doesn't support javascript.
loading
Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements.
Jackson, Katherine J L; Liu, Yi; Roskin, Krishna M; Glanville, Jacob; Hoh, Ramona A; Seo, Katie; Marshall, Eleanor L; Gurley, Thaddeus C; Moody, M Anthony; Haynes, Barton F; Walter, Emmanuel B; Liao, Hua-Xin; Albrecht, Randy A; García-Sastre, Adolfo; Chaparro-Riggers, Javier; Rajpal, Arvind; Pons, Jaume; Simen, Birgitte B; Hanczaruk, Bozena; Dekker, Cornelia L; Laserson, Jonathan; Koller, Daphne; Davis, Mark M; Fire, Andrew Z; Boyd, Scott D.
Afiliação
  • Jackson KJ; Department of Pathology, School of Medicine, Stanford University, Stanford, CA 94305, USA; School of Biotechnology and Biomolecular Science, University of New South Wales, Sydney, NSW 2052, Australia.
  • Liu Y; Biomedical Informatics Training Program, Stanford University, Stanford, CA 94305, USA.
  • Roskin KM; Department of Pathology, School of Medicine, Stanford University, Stanford, CA 94305, USA.
  • Glanville J; Department of Pathology, School of Medicine, Stanford University, Stanford, CA 94305, USA.
  • Hoh RA; Department of Pathology, School of Medicine, Stanford University, Stanford, CA 94305, USA.
  • Seo K; Department of Pathology, School of Medicine, Stanford University, Stanford, CA 94305, USA.
  • Marshall EL; Department of Genetics, School of Medicine, Stanford University, Stanford, CA 94305, USA.
  • Gurley TC; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Moody MA; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Haynes BF; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Walter EB; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Liao HX; Duke Human Vaccine Institute, Durham, NC 27710, USA.
  • Albrecht RA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • García-Sastre A; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Chaparro-Riggers J; Protein Engineering, Rinat-Pfizer Inc., South San Francisco, CA 94080, USA.
  • Rajpal A; Protein Engineering, Rinat-Pfizer Inc., South San Francisco, CA 94080, USA.
  • Pons J; Protein Engineering, Rinat-Pfizer Inc., South San Francisco, CA 94080, USA.
  • Simen BB; 454 Life Sciences Corporation, a Roche Company, Branford, CT 06405, USA.
  • Hanczaruk B; 454 Life Sciences Corporation, a Roche Company, Branford, CT 06405, USA.
  • Dekker CL; Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.
  • Laserson J; Department of Computer Science, Stanford University, Stanford, CA 94305, USA.
  • Koller D; Department of Computer Science, Stanford University, Stanford, CA 94305, USA.
  • Davis MM; Department of Microbiology and Immunology and Institute for Immunity, Transplantation, and Infection, Stanford University, Stanford, CA 94305, USA; Howard Hughes Medical Institute.
  • Fire AZ; Department of Pathology, School of Medicine, Stanford University, Stanford, CA 94305, USA; Department of Genetics, School of Medicine, Stanford University, Stanford, CA 94305, USA.
  • Boyd SD; Department of Pathology, School of Medicine, Stanford University, Stanford, CA 94305, USA. Electronic address: sboyd1@stanford.edu.
Cell Host Microbe ; 16(1): 105-14, 2014 Jul 09.
Article em En | MEDLINE | ID: mdl-24981332
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Rearranjo Gênico do Linfócito B / Influenza Humana / Anticorpos Antivirais Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Rearranjo Gênico do Linfócito B / Influenza Humana / Anticorpos Antivirais Limite: Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article